Literature DB >> 20199601

NAD+ auxotrophy is bacteriocidal for the tubercle bacilli.

Catherine Vilchèze1, Brian Weinrick, Ka-Wing Wong, Bing Chen, William R Jacobs.   

Abstract

The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD(+) using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD(+)de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovisDeltanadABC fails to grow in mice, whereas M. tuberculosisDeltanadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovisDeltanadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD(+) starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199601      PMCID: PMC2945688          DOI: 10.1111/j.1365-2958.2010.07099.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  43 in total

1.  Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis.

Authors:  Bhavna G Gordhan; Debbie A Smith; Heidi Alderton; Ruth A McAdam; Gregory J Bancroft; Valerie Mizrahi
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Synthesis of B-complex vitamins by tubercle bacilli when grown on synthetic media.

Authors:  H POPE; D T SMITH
Journal:  Am Rev Tuberc       Date:  1946-12

Review 3.  The biosynthesis of nicotinamide adenine dinucleotides in bacteria.

Authors:  T P Begley; C Kinsland; R A Mehl; A Osterman; P Dorrestein
Journal:  Vitam Horm       Date:  2001       Impact factor: 3.421

4.  pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Authors:  S J Cheng; L Thibert; T Sanchez; L Heifets; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 5.  Mycobacterium bovis infection in human beings.

Authors:  J M Grange
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

6.  Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli.

Authors:  Ka-Yiu San; George N Bennett; Susana J Berríos-Rivera; Ravi V Vadali; Yea-Tyng Yang; Emily Horton; Fred B Rudolph; Berna Sariyar; Kimathi Blackwood
Journal:  Metab Eng       Date:  2002-04       Impact factor: 9.783

7.  Enzyme activities leading to NAD synthesis in human lymphocytes.

Authors:  S Sestini; G Jacomelli; M Pescaglini; V Micheli; G Pompucci
Journal:  Arch Biochem Biophys       Date:  2000-07-15       Impact factor: 4.013

8.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling.

Authors:  Joanna C Betts; Pauline T Lukey; Linda C Robb; Ruth A McAdam; Ken Duncan
Journal:  Mol Microbiol       Date:  2002-02       Impact factor: 3.501

9.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

10.  Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates.

Authors:  D A Smith; T Parish; N G Stoker; G J Bancroft
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

View more
  34 in total

1.  Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection.

Authors:  Leonardo Sorci; Ian Blaby; Jessica De Ingeniis; Svetlana Gerdes; Nadia Raffaelli; Valérie de Crécy Lagard; Andrei Osterman
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.

Authors:  Anthony D Baughn; Jiaoyu Deng; Catherine Vilchèze; Angelica Riestra; John T Welch; William R Jacobs; Oren Zimhony
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

3.  A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.

Authors:  Jee-Hyun Kim; Kathryn M O'Brien; Ritu Sharma; Helena I M Boshoff; German Rehren; Sumit Chakraborty; Joshua B Wallach; Mercedes Monteleone; Daniel J Wilson; Courtney C Aldrich; Clifton E Barry; Kyu Y Rhee; Sabine Ehrt; Dirk Schnappinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 4.  Mycobacterium tuberculosis in the Face of Host-Imposed Nutrient Limitation.

Authors:  Michael Berney; Linda Berney-Meyer
Journal:  Microbiol Spectr       Date:  2017-06

Review 5.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

6.  Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.

Authors:  Brandon C Rosen; Nicholas A Dillon; Nicholas D Peterson; Yusuke Minato; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 7.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

8.  The Riemerella anatipestifer AS87_01735 Gene Encodes Nicotinamidase PncA, an Important Virulence Factor.

Authors:  Xiaolan Wang; Beibei Liu; Yafeng Dou; Hongjie Fan; Shaohui Wang; Tao Li; Chan Ding; Shengqing Yu
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

9.  Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.

Authors:  Feng Wang; Dhinakaran Sambandan; Rajkumar Halder; Jianing Wang; Sarah M Batt; Brian Weinrick; Insha Ahmad; Pengyu Yang; Yong Zhang; John Kim; Morad Hassani; Stanislav Huszar; Claudia Trefzer; Zhenkun Ma; Takushi Kaneko; Khisi E Mdluli; Scott Franzblau; Arnab K Chatterjee; Kai Johnsson; Kai Johnson; Katarina Mikusova; Gurdyal S Besra; Klaus Fütterer; Scott H Robbins; S Whitney Barnes; John R Walker; William R Jacobs; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

10.  Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis.

Authors:  Michael Berney; Linda Berney-Meyer; Ka-Wing Wong; Bing Chen; Mei Chen; John Kim; Jingxin Wang; David Harris; Julian Parkhill; John Chan; Feng Wang; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.